Trypanosoma cruzi: Sensitivity to selective drugs in phylogenetically unrelated stocks

Experimental Parasitology

Volumn 94, Issue 1, 2000, Pages 60-61

  Laurent, Jean Pierre ^a   Swindle, John ^a  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC G 418; HYGROMYCIN B;

ARTICLE; DRUG SENSITIVITY; NONHUMAN; PARASITE DEVELOPMENT; PHYLOGENY; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0033956377     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1999.4468     Document Type: Article

References (11)

1. Ajioka J., Swindle J. The calmodulin-ubiquitin (CUB) genes of Trypanosoma cruzi are essential for parasite viability. Molecular and Biochemical Parasitology. 78:1996;217-225.
2. Andrade S. G. Influence of Trypanosoma cruzi on the pathogenesis of chronic myocardiopathy in mice. Memorias do Instituto Oswaldo Cruz, Rio de Janeiro. 85:1990;17-27.
3. Bakker E. P. J. Aminoglycoside and aminocyclitol antibiotics: Hygromycin B is an atypical bactericidal compound that exerts effects on cells of Escherichia coli characteristics for bacteriostatic aminocyclitols. Journal of General Microbiology. 138:1992;563-569.
4. Dvorak J. A. The natural heterogeneity of Trypanosoma cruzi: Biological and medical implications. Journal of Cellular Biochemistry. 24:1984;357-371.
5. Laurent J.-P., Barnabé C., Quesney V., Noel S., Tibayrenc M. Clonal evolution and biological diversity of Trypanosoma cruzi. Parasitology. 114:1997;213-218.
6. Nunes L. R., Carvalho M. R., Shakarian A. M., Buck G. A. The transcription promoter of the spliced leader gene from Trypanosoma cruzi. Gene. 188:1997;157-168.
7. Revollo S., Oury B., Laurent J.-P., Barnabé C., Quesney V., Carrière V., Noël S., Tibayrenc M. Trypanosoma cruzi: Impact of clonal evolution of the parasite on its biological and medical properties. Experimental Parasitology. 89:1998;30-39.
8. Souto R. P., Fernandes O., Macedo A. M., Campbell D. A., Zingales B. DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Molecular and Biochemical Parasitology. 83:1996;141-152.
9. Swindle J., Gillespie R. D., Hariharan S., Chung S.-H., Ajioka J. Gene replacements and Genetics in Trypanosoma cruzi. Boothroyd J. C., Komuniecki R., Molecular Approaches to Parasitology. 12:1995;296-280.
10. Tibayrenc M., Ward P., Moya A., Ayala F. J. Natural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure. Proceedings of the National Academy of Science, USA. 83:1986;115-119.
11. Tibayrenc M. Population genetics of parasitic protozoa and other microorganisms. Advances in Parasitology. 36:1995;47-115.